Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
SHANK3 (also known as ProSAP2) regulates the structural organization of dendritic spines and is a binding partner of neuroligins; genes encoding neuroligins are mutated in autism and Asperger syndrome. Here, we report that a mutation of a single copy of SHANK3 on chromosome 22q13 can result in language and/or social communication disorders. These mutations concern only a small number of individuals, but they shed light on one gene dosage-sensitive synaptic pathway that is involved in autism spectrum disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Loss of a functional copy of the SHANK3 gene leads to the neurobehavioral manifestations of 22q13 deletion syndrome and/or to autism spectrum disorders.”
From Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication (2010) · cites this paper as [26]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The variations identified included de novo deleterious mutations and inherited non-synonymous variations affecting highly conserved amino acids in the ankyrin domain.6, 7”
From SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism (2012) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The remaining three mutations are non-synonymous mutations located in or near the highly conserved ankyrin domain (R12C, R300C and Q321R, referred to as Shank3R12C, Shank3R300C and Shank3Q321R, respectively).6, 7”
From SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism (2012) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent human genetic studies indicate that SHANK family genes (SHANK1, SHANK2, and SHANK3) are causative genes for idiopathic autism spectrum disorders (ASD).”
From Modeling Autism by SHANK Gene Mutations in Mice (2013) · cites this paper as Durand et al., 2007
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In three families from France and Canada, the SHANK3 deletions originated from a balanced translocation present in a healthy parent [6], [13].”
From Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: A Gradient of Severity in Cognitive Impairments (2014) · cites this paper as [6]
Experimental — accuracy not yet measured
21 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A forkhead-domain gene is mutated in a severe speech and language disorder
Lai, C. S. L., Fisher, S. E., Hurst, J. A., Vargha-Khadem, F., & Monaco, A. P. (2001) · Nature · doi:10.1038/35097076 · Cited by 2,054
Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism
Study, P. A. R. I. S., Jamain, S., Quach, H., Betancur, C., Råstam, M., Colineaux, C., Gillberg, I. C., Soderstrom, H., Giros, B., Leboyer, M., et al. (2003) · Nature Genetics · doi:10.1038/ng1136 · Cited by 1,851
Self-citationNaisbitt, S., Kim, E., Tu, J. C., Xiao, B., Sala, C., Valtschanoff, J., Weinberg, R. J., Worley, P. F., & Sheng, M. (1999) · Neuron · doi:10.1016/s0896-6273(00)80809-0 · Cited by 1,009
Genetics of austim: complex aetiology for a heterogeneous disorder
Folstein, S. E., & Rosen-Sheidley, B. (2001) · Nature Reviews Genetics · doi:10.1038/35103559 · Cited by 771
Searching for ways out of the autism maze: genetic, epigenetic and environmental clues
Persico, A. M., & Bourgeron, T. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.05.010 · Cited by 575
Self-citationVorstman, J. A. S., Staal, W. G., van Daalen, E., van Engeland, H., Hochstenbach, P. F. R., & Franke, L. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001757 · Cited by 353
Spine architecture and synaptic plasticity
Carlisle, H. J., & Kennedy, M. B. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.01.008 · Cited by 350
Boeckers, T. M., Bockmann, J., Kreutz, M. R., & Gundelfinger, E. D. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00931.x · Cited by 349
Self-citationSevere Expressive-Language Delay Related to Duplication of the Williams–Beuren Locus
Somerville, M. J., Mervis, C. B., Young, E. J., Seo, E.-J., del Campo, M., Bamforth, S., Peregrine, E., Loo, W., Lilley, M., Pérez-Jurado, L. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051962 · Cited by 312
Bonaglia, M. C., Giorda, R., Borgatti, R., Felisari, G., Gagliardi, C., Selicorni, A., & Zuffardi, O. (2001) · The American Journal of Human Genetics · doi:10.1086/321293 · Cited by 309
Cited by
Items 601–700 of 1,004
Connolly, S., Anney, R., Gallagher, L., & Heron, E. A. (2016) · European Journal of Human Genetics · doi:10.1038/ejhg.2016.153 · Cited by 44
“Mutations in SHANK3 are well known risk factors for ASD [49].”
BackgroundGrzadzinski, R., Lord, C., Sanders, S., Werling, D. M., & Bal, V. H. (2017) · Autism Research · doi:10.1002/aur.1856 · Cited by 46
“2 mutations [Hanson et al., 2015] or explorations of individuals with SHANK3 mutations [Durand et al., 2007].”
BackgroundHippocampal Regulation of Postsynaptic Density Homer1 by Associative Learning
Clifton, N. E., Cameron, D., Trent, S., Sykes, L., Thomas, K. L., & Hall, J. (2017) · Neural Plasticity · doi:10.1155/2017/5959182 · Cited by 42
“Homer1 activity has been shown to influence the functioning of other proteins and protein complexes linked to psychiatric disorders through genetic variants, such as FMRP [28, 42, 43], CYFIP1 [27, 44, 45], Arc [27, 46], SHANK [10, 47, 48], and the calcium channel Cav1.”
InfluentialLuo, J., Norris, R. H., Gordon, S. L., & Nithianantharajah, J. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.12.001 · Cited by 39
Synapse-to-nucleus communication: from developmental disorders to Alzheimer's disease
Marcello, E. E., Luca, M. D., & Gardoni, F. (2018) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2017.12.017 · Cited by 44
Hypothesis‐driven investigations of diverse pharmacological targets in two mouse models of autism
Rhine, M. A., Parrott, J. M., Schultz, M. N., Kazdoba, T. M., & Crawley, J. N. (2019) · Autism Research · doi:10.1002/aur.2066 · Cited by 47
“3 deletion which causes Phelan-McDermid syndrome, a neurodevelopmental disorder presenting with intellectual impairments, seizures, and autism [Durand et al., 2007; Betancur & Buxbaum, 2013; Monteiro & Feng, 2017].”
BackgroundXu, N., Lv, H., Yang, T., Du, X., Sun, Y., Xiao, B., Fan, Y., Luo, X., Zhan, Y., Wang, L., et al. (2020) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-020-01592-5 · Cited by 43
Shankopathies in the Developing Brain in Autism Spectrum Disorders
Vyas, Y., Cheyne, J. E., Lee, K., Jung, Y., Cheung, P. Y., & Montgomery, J. M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.775431 · Cited by 54
Emerging themes in GABAergic synapse development
Kuzirian, M. S., & Paradis, S. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.07.002 · Cited by 43
Cho, S. C., Yim, S., Yoo, H. K., Kim, M., Jung, G. Y., Shin, G. W., Kim, B., Hwang, J. W., Kang, J., Kim, T., et al. (2009) · Psychiatric Genetics · doi:10.1097/ypg.0b013e32832bdafa · Cited by 42
“Concerning these complex inheritance patterns, various linkage analyses have suggested the involvement of more than 15 loci in ASD and recently, mutations in synaptic scaffolding gene SHANK3 was suggested to be associated with ASD (Risch et al., 1999; Durand et al., 2007).”
BackgroundPre-clinical models of neurodevelopmental disorders: focus on the cerebellum
Shevelkin, A. V., Ihenatu, C., & Pletnikov, M. V. (2014) · Reviews in the Neurosciences · doi:10.1515/revneuro-2013-0049 · Cited by 43
Epigenetics, genomic mutations and cognitive function
Reichenberg, A., Mill, J., & MacCabe, J. H. (2009) · Cognitive Neuropsychiatry · doi:10.1080/13546800902978417 · Cited by 40
Qin, L., Ma, K., & Yan, Z. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01212-1 · Cited by 46
“Enriched ASD mutations are located at the SHANK3 C-terminal region (exon 21) [11], which plays a crucial role in the synaptic targeting and postsynaptic assembly of Shank3 complex.”
BackgroundModeling dopamine dysfunction in autism spectrum disorder: from invertebrates to vertebrates
DiCarlo, G. E., & Wallace, M. T. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.12.017 · Cited by 39
The Role of Zinc and NMDA Receptors in Autism Spectrum Disorders
Lee, K. C., Mills, Z., Cheung, P. Y., Cheyne, J. E., & Montgomery, J. M. (2022) · Pharmaceuticals · doi:10.3390/ph16010001 · Cited by 43
Genetic and functional analyses identify DISC1 as a novel callosal agenesis candidate gene
Osbun, N. C., Jiang, L., O’Driscoll, M., Strominger, Z. A., Wakahiro, M. L. J., Rider, E., Bukshpun, P., Boland, E., Spurrell, C. H., Schackwitz, W., et al. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.34081 · Cited by 47
Addington, A. M., & Rapoport, J. L. (2011) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2011.02478.x · Cited by 44
“3 (Durand et al., 2007; Gauthier et al., 2009; Moessner et al., 2007), and CNTNAP2 on 7q35 (Bakkaloglu et al., 2008).”
Clinical and Neurobiological Relevance of Current Animal Models of Autism Spectrum Disorders
Kim, K. C., Gonzales, E. L., Lázaro, M. T., Choi, C. S., Bahn, G. H., Yoo, H. J., & Shin, C. Y. (2016) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2016.061 · Cited by 48
“Moreover, heterozygous mutations of SHANK3 may cause ASD in a gene-dosage-dependent manner (Durand et al., 2007).”
BackgroundInvestigation of SHANK3 in schizophrenia
Cortabitarte, A. D. S., Degenhardt, F., Strohmaier, J., Lang, M., Weiß, B., Roeth, R., Giegling, I., Heilmann‐Heimbach, S., Hofmann, A., Rujescu, D., et al. (2017) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32528 · Cited by 49
“In addition, while de novoCNVs involving the deletion of parts of SHANK3 have been reported in individuals with ASD and ID, no comparable CNVs have been reported to date in SCZ [Durand et al., 2007; Malhotra and Sebat, 2012; Moessner et al., 2007].”
BackgroundResultInfluentialSHANK genes in autism: Defining therapeutic targets
Mossa, A., Giona, F., Pagano, J., Sala, C., & Verpelli, C. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.11.019 · Cited by 46
Medina, M. A., Andrade, V., Caracci, M. O., Ávila, M. E., Verdugo, D. A., Vargas, M. F., Ugarte, G. D., Reyes, A. E., Opazo, C., & Ferrari, G. V. D. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0093-y · Cited by 45
Lee, S., Chun, H., Lee, J., Park, H., Kim, K., Kim, C., Yoon, S., & Kim, W. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203543 · Cited by 49
Brown, E. A., Lautz, J. D., Davis, T. R., Gniffke, E. P., VanSchoiack, A. A. W., Neier, S. C., Tashbook, N., Nicolini, C., Fahnestock, M., Schrum, A. G., et al. (2018) · Molecular Autism · doi:10.1186/s13229-018-0229-1 · Cited by 39
Addressing the Genetics of Human Mental Health Disorders in Model Organisms
McCammon, J. M., & Sive, H. L. (2015) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090314-050048 · Cited by 44
Rosato, M., Stringer, S., Gebuis, T., Paliukhovich, I., Li, K. W., Posthuma, D., Sullivan, P. F., Smit, A. B., & van Kesteren, R. E. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0436-y · Cited by 38
Doldur-Balli, F., Imamura, T., Veatch, O. J., Gong, N. N., Lim, D. C., Hart, M. P., Abel, T. G., Kayser, M. S., Brodkin, E. S., & Pack, A. I. (2022) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2022.101595 · Cited by 49
Lord, J. S., Gay, S. M., Harper, K. M., Nikolova, V. D., Smith, K. M., Moy, S. S., & Diering, G. H. (2022) · Molecular Autism · doi:10.1186/s13229-022-00514-5 · Cited by 46
“Heterozygous mutation or chromosomal loss of SHANK3 is causative of Phelan-McDermid syndrome, a severe neurodevelopmental condition associated with autism and sleep disruption (19-21).”
BackgroundInfluentialA molecular model for neurodevelopmental disorders
Gigek, C. O., Chen, E., Ota, V., Maussion, G., Peng, H., Vaillancourt, K., Diallo, A., López, J. P., Crapper, L., Vasuta, C., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.56 · Cited by 44
Wan, L., Ai, J.-Q., Yang, C. G., Jiang, J., Zhang, Q., Luo, Z., Huang, R., Tu, T., Pan, A., Tu, E., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.717263 · Cited by 40
Lutz, A.-K., Arévalo, A. P., Ioannidis, V., Stirmlinger, N., Demestre, M., Delorme, R., Bourgeron, T., & Boeckers, T. M. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.773571 · Cited by 39
Self-citationDesarkar, P., Rajji, T. K., Ameis, S. H., & Daskalakis, Z. J. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00124 · Cited by 46
“The examples of such mutations involve genes critically involved in (a) synaptic maturation, e.g., neuroligin 3 and 4 (10), c3orf58, NHE9, and PCDH10 (13); (b) neuronal migration, e.g., CNTNAP2 (12); and (c) dendritic development, e.g., SHANK3 (12). evidence from Animal Models of ASD Further evidence of aberrant neuro…”
Actin cytoskeleton dynamics in stem cells from autistic individuals
Griesi‐Oliveira, K., Suzuki, Â. M., Alves, A. Y., Mafra, A. C. C. N., Yamamoto, G. L., Ezquina, S., Magalhães, Y. T., Forti, F. L., Sertie, A. L., Zachi, E. C., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-29309-6 · Cited by 39
Genotype and phenotype correlations for SHANK3 de novo mutations in neurodevelopmental disorders
Li, Y., Jia, X., Wu, H., Xun, G., Ou, J., Zhang, Q., Li, H., Bai, T., Hu, Z., Zou, X., et al. (2018) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.40666 · Cited by 43
Valentino, F., Bruno, L. P., Doddato, G., Giliberti, A., Tita, R., Resciniti, S., Fallerini, C., Bruttini, M., Rizzo, C. L., Mencarelli, M. A., et al. (2021) · Brain Sciences · doi:10.3390/brainsci11070936 · Cited by 48
Novel copy number variants in children with autism and additional developmental anomalies
Davis, L. K., Meyer, K. J., Rudd, D. S., Librant, A. L., Epping, E. A., Sheffield, V. C., & Wassink, T. H. (2009) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-009-9013-z · Cited by 41
“Several of the recently highlighted mutations in autism, such as SHANK3 [7], NRXN1 [8, 19] and contactin 4 [38] have also been identified in parents, some of whom exhibit features of a broader autism phenotype.”
BackgroundAnimal model integration to AutDB, a genetic database for autism
Kumar, A., Wadhawan, R., Swanwick, C. C., Kollu, R., Basu, S. N., & Banerjee-Basu, S. (2011) · BMC Medical Genomics · doi:10.1186/1755-8794-4-15 · Cited by 23
“Furthermore, ASD is consistently associated with a number of specific genetic disorders caused by a single gene mutation, such as Fragile X Syndrome [14-17].”
BackgroundClaudio Toma, A., Amaia Hervas, G., Balmaña, N., Vilella, E., Aguilera, F., Cuscó, I., Campo, M. D., Caballero‐Andaluz, R., de Diego‐Otero, Y., Ribasés, M., et al. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.09.001 · Cited by 37
Gene expression analysis in lymphoblasts derived from patients with autism spectrum disorder
Yasuda, Y., Hashimoto, R., Yamamori, H., Ohi, K., Fukumoto, M., Umeda‐Yano, S., Mohri, I., Itô, A., Taniike, M., & Takeda, M. (2011) · Molecular Autism · doi:10.1186/2040-2392-2-9 · Cited by 42
“In addition, neuroligins interact with a postsynaptic scaffolding protein, SHANK3, which is also implicated in ASD [17] and is located on the telomeric terminal of chromosome 22q13.”
BackgroundNESH Regulates Dendritic Spine Morphology and Synapse Formation
Bae, J., Sung, B. H., Cho, I. H., Kim, S.-M., & Song, W. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034677 · Cited by 36
“Stressing this idea, in various neuronal disorders, numerous mutations or variants have been identified in postsynaptic molecules involved in regulating spine morphogenesis [48,49,50].”
BackgroundGenetic background modulates phenotypes of serotonin transporter Ala56 knock-in mice
Kerr, T. M., Muller, C. L., Miah, M., Jetter, C. S., Pfeiffer, R., Shah, C., Baganz, N., Anderson, G. M., Crawley, J. N., Sutcliffe, J. S., et al. (2013) · Molecular Autism · doi:10.1186/2040-2392-4-35 · Cited by 36
“Multiple examples of convergent phenotypes with increased or decreased gene dosage or function have been described in ASD human genetic studies, including MECP2 deletion and duplication [63-65], chromosome 16p11 deletion and duplication [66], and SHANK3 deletion and duplication [67].”
BackgroundMisceo, D., Rødningen, O. K., Barøy, T., Sorte, H., Mellembakken, J. R., Strømme, P., Fannemel, M., & Frengen, E. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33798 · Cited by 36
“Moreover, SHANK3 point mutations are detected in<1% of the patients ascertained not for a syndromic phenotype, but for autism [Durand et al., 2007; Moessner et al., 2007; Gauthier et al., 2009].”
BackgroundLee, Y., Kang, H., Lee, B., Zhang, Y., Kim, Y., Kim, S., Kim, W.-K., & Han, K. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00110 · Cited by 42
“Importantly, Zhou et al. (2016) recently demonstrated that two different Shank3 knock-in (KI) mice modeling the human mutations of ASD (InsG3680) and SCZ (R1117X) display STR- and PFC-specific synaptic defects, respectively.”
BackgroundInfluentialAssociation of genes with phenotype in autism spectrum disorder
Nisar, S., Hashem, S., Bhat, A. A., Syed, N., Yadav, S. K., Azeem, M. W., Shahab Uddin, M. S., Bagga, P., Reddy, R. D., & Haris, M. (2019) · Aging · doi:10.18632/aging.102473 · Cited by 41
“There have also been reports of X-linked mutations in NLGN3 and NLGN4 in ASD that affect synapse formation and maintenance, which is important for speech development and social communication [58].”
BackgroundFan, C.-X., Gao, Y., Liang, G., Huang, L., Wang, J., Yang, X., Shi, Y., Dräger, U. C., Zhong, M., Gao, T., et al. (2020) · Molecular Autism · doi:10.1186/s13229-020-0318-9 · Cited by 40
“Targeted studies have identified several synaptic cell adhesion molecules such as neuroligins (NLGN3, NLGN4) [10], neurexins (NRXN1 [11], CNTNAP2 [12]), scaffolding proteins SHANK2 [13] and SHANK3 [14], and other molecules in synaptic transmission [15–17].”
BackgroundAutism - A Neurodevelopmental Journey from Genes to Behaviour
(2011) · InTech eBooks · doi:10.5772/974 · Cited by 36
A Comparative Perspective on Wnt/β-Catenin Signalling in Cell Fate Determination
Garcin, C. L., & Habib, S. J. (2017) · Results and problems in cell differentiation · doi:10.1007/978-3-319-53150-2_15 · Cited by 43
Ciuculete, D. M., Voisin, S., Kular, L., Jonsson, J., Rask-Andersen, M., Mwinyi, J., & Schiöth, H. B. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00884-8 · Cited by 35
Urrutia‐Ruiz, C., Rombach, D., Cursano, S., Gerlach-Arbeiter, S., Schoen, M., Bockmann, J., Demestre, M., & Boeckers, T. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116081 · Cited by 38
“Indeed, ∼1% of the ASD cases are caused by mutations or haploinsufficiency in the SHANK3 gene [4], the first isoform described to cause ASD among the three ProSAP/Shank protein family members [5].”
BackgroundSelf-citationHuman Inducible Pluripotent Stem Cells and Autism Spectrum Disorder: Emerging Technologies
Nestor, M. W., Phillips, A. W., Artimovich, E., Nestor, J. E., Hussman, J. P., & Blatt, G. J. (2016) · Autism Research · doi:10.1002/aur.1570 · Cited by 35
“5% of those with ASD and is also found in ASD-related conditions Fragile-X syndrome and tuberous sclerosis [Darnell et al., 2011; Durand et al., 2006; Moessner et al., 2007; Gauthier et al., 2009; Sakai et al., 2011; Soorya et al., 2013].”
BackgroundInfluentialMicroRNA-7/Shank3 axis involved in schizophrenia pathogenesis
Zhang, J., Sun, X., & Zhang, L.-Y. (2015) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2015.01.031 · Cited by 38
“Recently, mutations in the SHANK3 gene were found in patients with autism spectrum disorder [8,11,25].”
BackgroundQuantifying and Modeling Birth Order Effects in Autism
Turner, T., Pihur, V., & Chakravarti, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026418 · Cited by 34
“The most convincing genetic etiologies arise from syndromes which display autism as one part of the phenotype, such as the Fragile(X) [2] and Rett [3], or other single genes with rare mutations in autism, such as those in SHANK3 [4,5].”
BackgroundMutations affecting synaptic levels of neurexin-1β in autism and mental retardation
Camacho-Garcia, R. J., Planelles, M. I., Margalef-Català, M., Pecero, M. L., Martínez‐Leal, R., Aguilera, F., Vilella, E., Martínez-Mir, A., & Scholl, F. G. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.03.031 · Cited by 44
“All doi:10.1016/j.nbd.2012.03.031 a b s t r a c t a r t i c l e i n f o”
MethodInfluentialChen, C., Lin, S.-P., Chern, S., Tsai, F., Wu, P.-C., Lee, C., Chen, Y., Chen, W.-L., & Wang, W. (2010) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2010.06.004 · Cited by 36
Robert, C., Pasquier, L., Cohen, D., Fradin, M., Canitano, R., Damaj, L., Odent, S., & Tordjman, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030618 · Cited by 43
Qin, Y., Du, Y., Chen, L., Liu, Y., Xu, W., Liu, Y., Li, Y., Leng, J., Wang, Y., Zhang, X., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01539-1 · Cited by 35
“SHANK family genes (SHANK1/2/3) are wellknown ASD-related genes with multiple types of molecular defects [7], since the first report of SHANK3 mutations in ASD patients was published in 2007 [8].”
BackgroundPescosolido, M. F., Uzun, E. D. G., Nagpal, S., & Morrow, E. M. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.01.003 · Cited by 42
Richards, C., Powis, L., Moss, J. F., Stinton, C., Nelson, L., & Oliver, C. (2017) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-017-9217-6 · Cited by 35
“The putative association between ASD and PMS is of particular interest as the SHANK3 gene is one of the many implicated in the aetiology of idiopathic ASD [3, 16, 17] with SHANK3 deficiency associated with 0.”
BackgroundZhu, M., Idikuda, V. K., Wang, J., Wei, F., Kumar, V., Shah, N., Waite, C. B., Liu, Q., & Zhou, L. (2018) · The Journal of Physiology · doi:10.1113/jp275147 · Cited by 35
Sequencing ASMT Identifies Rare Mutations in Chinese Han Patients with Autism
Wang, L., Li, J., Ruan, Y., Lu, T., Liu, C., Jia, M., Yue, W., Liu, J., Bourgeron, T., & Zhang, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053727 · Cited by 38
“Previous researches had found rare variants in SHANK2, SHANK3, NLGN3, NLGN4 and other genes in a subset of patients with ASD [7–9].”
ResultSelf-citationXu, L., Ren, Z., Chow, F. E., Tsai, R., Liu, T., Rizzolio, F., Boffo, S., Xu, Y., Huang, S., Lippa, C. F., et al. (2017) · Neural Plasticity · doi:10.1155/2017/3270725 · Cited by 33
USP8 Deubiquitinates SHANK3 to Control Synapse Density and SHANK3 Activity-Dependent Protein Levels
Campbell, M. K., & Sheng, M. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.3305-17.2018 · Cited by 39
“Additionally, mutations in the SHANK3 gene are estimated to contribute to 1% of ASDs (Durand et al., 2007; Gauthier et al., 2009; Boccuto et al., 2013; Leblond et al., 2014) and may also play a role in schizophrenia (Failla et al., 2007; Choi et al., 2015; de Sena Cortabitarte et al., 2017).”
BackgroundZhang, Y., Ding, R., Wang, S., Ren, Z., Xu, L., Zhang, X., Zhao, J., Ding, Y., Wu, Y., & Gong, Y. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6487 · Cited by 35
“PSD is an important structure that affects neuronal synaptic plasticity (13).”
Chopra, M., McEntagart, M., Clayton‐Smith, J., Platzer, K., Shukla, A., Girisha, K. M., Kaur, A., Kaur, P., Pfundt, R., Veenstra‐Knol, H. E., et al. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.04.007 · Cited by 38
The Neurological Manifestations of Phelan-McDermid Syndrome
Frank, Y. (2021) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2021.06.002 · Cited by 40
Twenty years of discoveries emerging from mouse models of autism
Crawley, J. N. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105053 · Cited by 37
CNVs leading to fusion transcripts in individuals with autism spectrum disorder
Holt, R., Sykes, N., Conceição, I. C., Cazier, J., Anney, R., Oliveira, G., Gallagher, L., Vicente, A. M., Monaco, A. P., & Pagnamenta, A. T. (2012) · European Journal of Human Genetics · doi:10.1038/ejhg.2012.73 · Cited by 41
Lu, C., Chen, Q., Zhou, T. G., Bozic, D., Fu, Z., Pan, J. Q., & Feng, G. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.173 · Cited by 38
Bucher, M., Niebling, S., Han, Y., Molodenskiy, D., Hassani Nia, F., Kreienkamp, H.-J., Svergun, D., Kim, E., Kostyukova, A. S., Kreutz, M. R., et al. (2021) · eLife · doi:10.7554/elife.66165 · Cited by 33
Pagano, J., Landi, S., Stefanoni, A., Nardi, G., Albanesi, M., Bauer, H. F., Pracucci, E., Schön, M., Ratto, G. M., Boeckers, T. M., et al. (2023) · Molecular Autism · doi:10.1186/s13229-023-00557-2 · Cited by 40
“Of note numerous studies have linked the SHANK3 gene with ASD [6–8], and it is estimated that mutations or deletions in the SHANK3 gene account for approximately 1% of all ASD cases [8].”
BackgroundSelf-citationBrief Report: Sensory Reactivity in Children with Phelan–McDermid Syndrome
Mieses, A. M., Tavassoli, T., Li, E. A., Soorya, L. V., Lurie, S., Wang, A. T., Siper, P. M., & Kolevzon, A. (2016) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-016-2754-0 · Cited by 34
“…Medicine at Mount Sinai, New York, NY, USA 5 Mindich Child Health Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA SHANK3 gene (Durand et al. 2007) on terminal chromosome 22q, which codes for a master scaffolding protein necessary for glutamatergic synapses and their function…”
Breckpot, J., Vercruyssen, M., Weyts, E., Vandevoort, S., D'Haenens, G., Buggenhout, G. V., Leempoels, L., Brischoux‐Boucher, E., Maldergem, L. V., Renieri, A., et al. (2016) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2016.08.003 · Cited by 34
Dosage-sensitive genes in autism spectrum disorders: From neurobiology to therapy
Javed, S., Selliah, T., Lee, Y., & Huang, W. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.08.009 · Cited by 36
Ahadullah, Yau, S., Lu, H., Lee, T. M. C., Guo, H., & Chan, C. C. H. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.06.043 · Cited by 33
Krüttner, S., Falasconi, A., Valbuena, S., Galimberti, I., Bouwmeester, T., Arber, S., & Caroni, P. (2022) · Neuron · doi:10.1016/j.neuron.2022.02.001 · Cited by 33
Association study of the CNS patterning genes and autism in Han Chinese in Taiwan
Chien, Y., Wu, Y., Chiu, Y., Liu, S.-K., Tsai, W., Lin, P., Chen, C., Gau, S. S., & Chien, W. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.04.010 · Cited by 37
Atypical Antipsychotics in Children with Pervasive Developmental Disorders
Chavez, B., Chávez-Brown, M., Sopko, M. A., & Rey, J. A. (2007) · Pediatric Drugs · doi:10.2165/00148581-200709040-00006 · Cited by 36
“Pediatr Drugs 2007; 9 (4) the role of irregular segments of genetic code or other factors that Historically, conventional antipsychotics, such as haloperidol, might result in higher susceptibility to a diagnosis of PDD.[15] In have been used to treat children with PDDs.”
MethodInfluentialAssociation study of SHANK3 gene polymorphisms with autism in Chinese Han population
Qin, J., Jia, M., Wang, L., Lu, T., Ruan, Y., Liu, J., Guo, Y., Zhang, J., Yang, X., Yue, W., et al. (2009) · BMC Medical Genetics · doi:10.1186/1471-2350-10-61 · Cited by 33
“One is a G insertion, and the other is a deletion of the terminal 22q13 with the breakpoint in intron8 of SHANK3[17].”
InfluentialKolevzon, A., Cai, G., Soorya, L. V., Takahashi, N., Grodberg, D., Kajiwara, Y., Willner, J. P., Tryfon, A., & Buxbaum, J. D. (2010) · Brain Research · doi:10.1016/j.brainres.2010.11.005 · Cited by 32
Autism throughout genetics: Perusal of the implication of ion channels
Daghsni, M., Rima, M., Fajloun, Z., Ronjat, M., Brusés, J. L., Mrad, R., & WAARD, M. M. D. (2018) · Brain and Behavior · doi:10.1002/brb3.978 · Cited by 37
Huang, L., Wang, J., Liang, G., Gao, Y., Jin, S., Hu, J., Yang, X., Lao, J., Chen, J., Luo, Z.-C., et al. (2021) · Theranostics · doi:10.7150/thno.60531 · Cited by 33
“Multiple lines of evidence indicate that ASD is associated with mutations in many genes that affect the ratio between neuronal excitation and inhibition [6-9].”
BackgroundMachine Learning-Based Blood RNA Signature for Diagnosis of Autism Spectrum Disorder
Voinsky, I., Fridland, O. Y., Aran, A. A., Frye, R. E., & Gurwitz, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032082 · Cited by 41
“Common contributors to the development of the disorder include point mutations [6], copy number variants (CNVs) [7], translocations [8], DNA methylation [9], histone modifications [10], miRNAs expression [11], mitochondrial deficiencies [12], viral infections [13,14], aberrant gut microbiome composition [15], parental…”
BackgroundMa, K., Taylor, C., Williamson, M., Newton, S. S., & Qin, L. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1182472 · Cited by 38
“Haploinsufficiency of the SHANK3 due to deletions or de novo mutations has been linked to autism (2, 16, 17).”
BackgroundUltrastructural analyses in the hippocampus CA1 field in Shank3-deficient mice
Uppal, N., Puri, R., Yuk, F., Janssen, W. G. M., Bozdagi-Gunal, O., Harony-Nicolas, H., Dickstein, D. L., Buxbaum, J. D., & Hof, P. R. (2015) · Molecular Autism · doi:10.1186/s13229-015-0036-x · Cited by 32
“Upon further analysis, SHANK3 variants were identified in patients ascertained with autism [9, 11, 13, 16–18].”
BackgroundMomoi, T., Fujita, E., Senoo, H., & Momoi, M. Y. (2010) · Cell Biology International · doi:10.1042/cbi20090250 · Cited by 34
Modeling of Autism Genetic Variations in Mice: Focusing on Synaptic and Microcircuit Dysfunctions
Qiu, S., Aldinger, K. A., & Levitt, P. R. (2012) · Developmental Neuroscience · doi:10.1159/000336644 · Cited by 33
Baecker, T., Mangus, K., Pfaender, S., Chhabra, R., Boeckers, T. M., & Grabrucker, A. M. (2014) · BioMetals · doi:10.1007/s10534-014-9764-1 · Cited by 36
Self-citationKimura, H., Tsuboi, D., Wang, C., Kushima, I., Koide, T., Ikeda, M., Iwayama, Y., Toyota, T., Yamamoto, N., Kunimoto, S., et al. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu147 · Cited by 38
Developing new pharmacotherapies for autism
Ecker, C., Spooren, W., & Murphy, D. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12113 · Cited by 31
Genetics of Autism Spectrum Disorders
Rutter, M., & Thapar, A. (2014) · Handbook of Autism and Pervasive Developmental Disorders, Fourth Edition · doi:10.1002/9781118911389.hautc17 · Cited by 31
Are retinoids potential therapeutic agents in disorders of social cognition including autism?
Ebstein, R. P., Mankuta, D., Yirmiya, N., & Malavasi, F. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.05.004 · Cited by 31
“Rare de novo mutations of high penetrancefor ASD have been identified in synaptic genes, includingNLGN3,NLGN4XandSHANK3 [100–102].”
BackgroundTorres, E. B., Nguyen, J., Mistry, S., Whyatt, C. P., Kalampratsidou, V., & Kolevzon, A. (2016) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2016.00022 · Cited by 32
“…Jin, The Salk Institute for Biological Studies, USA Alexandra Lyndon Bey, Duke University, USA *Correspondence: Elizabeth B. Torres ebtorres@rci.rutgers.edu Received: 22 April 2016 Accepted: 07 June 2016 Published: 27 June 2016 Citation: Torres EB, Nguyen J, Mistry S, Whyatt C,…”
BackgroundOron, O., & Elliott, E. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040828 · Cited by 33
“The most notable gene in this CNV is SHANK3/PROSAP2, where mutations in this gene alone have been shown to be associated with ASD [16,17].”
BackgroundCammarata-Scalisi, F., Callea, M., Martinelli, D., Willoughby, C. E., Tadich, A. C., Castillo, M. A., Lacruz-Rengel, M. A., Medina, M., Grimaldi, P., Bertini, E., et al. (2022) · Genes · doi:10.3390/genes13030504 · Cited by 37
Prenatal Zinc Deficient Mice as a Model for Autism Spectrum Disorders
Sauer, A. K., Hagmeyer, S., & Grabrucker, A. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116082 · Cited by 35
Modeling SHANK3-associated autism spectrum disorder in Beagle dogs via CRISPR/Cas9 gene editing
Tian, R., Li, Y., Zhao, H., Lyu, W., Zhao, J., Wang, X., Lu, H., Xu, H., Ren, W., Tan, Q.-Q., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02276-9 · Cited by 35
“Since SHANK3 mutation is the fi rst and one of the most replicated genetic risks for idiopathic ASD [1 – 5, 21, 22] and our team has extensive experience in modeling SHANK3 -associated ASD in mice and monkey [10, 11, 23, 24], we aimed to develop Shank3 mutant dog models for this exploratory…”
Rare genetic brain disorders with overlapping neurological and psychiatric phenotypes
Peall, K. J., Owen, M. J., & Hall, J. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00896-x · Cited by 37
“Given this long association of SHANK3 with ASD 95 , a meta-analysis of SHANK3 point mutations and CNVs was conducted to determine their overall prevalence and clinical importance in ASD 96 .”
Genomics and Autism Spectrum Disorder
Johnson, N. L., Giarelli, E., Lewis, C., & Rice, C. E. (2013) · Journal of Nursing Scholarship · doi:10.1111/j.1547-5069.2012.01483.x · Cited by 36
Glutamatergic candidate genes in autism spectrum disorder: an overview
Chiocchetti, A. G., Bour, H. S., & Freitag, C. M. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1161-y · Cited by 34
De novo SHANK3 mutation causes Rett syndrome‐like phenotype in a female patient
Hara, M., Ohba, C., Yamashita, Y., Saitsu, H., Matsumoto, N., & Matsuishi, T. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36775 · Cited by 32
“Mutations in SHANK3 and NLG3/4 encoding these molecules affecting neurite development were identified in autism spectrum disorders (ASD) or ID [Durand et al., 2007].”
BackgroundInfluentialLiu, C., Peng, X., Hu, C.-C., Li, C., Li, Q., & Xu, X. (2016) · Development Genes and Evolution · doi:10.1007/s00427-016-0561-4 · Cited by 39
“Five intragenic promoters (Wang et al., 2011; Jiang and Ehlers, 2013; Zhu et al., 2014) and extensive alternative splice variants have been identified in mouse and human SHANK3 (Lim et al., 1999; Wilson et al., 2003; Durand et al., 2007), which all contribute to the diversity of Shank3 transcripts.”
Background
Metadata
- Authors
- Durand, C. M., Betancur, C., Boeckers, T. M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I. C., Anckarsäter, H., Sponheim, E., Goubran-Botros, H., Delorme, R., Chabane, N., Mouren-Simeoni, M.-C., de Mas, P., Bieth, E., Rogé, B., Héron, D., Burglen, L., Gillberg, C., Leboyer, M., & Bourgeron, T.
- Affiliations
- Institut Pasteur (FR)
- Inserm (FR)
- Universität Ulm (DE)
- University of Gothenburg (SE)
- University of Oslo (NO)
- Assistance Publique – Hôpitaux de Paris (FR)
- Université Toulouse - Jean Jaurès (FR)
- Pitié-Salpêtrière Hospital (FR)
- St George's Hospital (GB)
- Corresponding author
- Bourgeron, Thomas
- ORCID
- Venue
- Nature Genetics
- Published
- 2006-12-17
- Volume
- 39
- Issue
- 1
- Pages
- 25-27
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- PMC
- PMC2082049
- OpenAlex
- W1983194657
- Cited by
- 1,602
- References
- 16
- Citations by year
- 2026: 48 · 2025: 40 · 2024: 75 · 2023: 71 · 2022: 78 · 2021: 91 · 2020: 85 · 2019: 68 · 2018: 81 · 2017: 99 · 2016: 79 · 2015: 96 · 2014: 78 · 2013: 97 · 2012: 114
- FWCI
- 33.51
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion, other-oa)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- George Washington University
- Georgetown University
- Children's National Hospital
- European Commission
- Deutsche Forschungsgemeinschaft (SFB 497)
- Institut National de la Santé et de la Recherche Médicale
- Fondation pour la Recherche Médicale
- Fondation de France
- Universitetet i Oslo
- Assistance publique-Hôpitaux de Paris
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- SHANK3, autism spectrum disorder, neuroligins, dendritic spines, synaptic scaffolding, chromosome 22q13, gene dosage sensitivity, language disorders, social communication disorder, Asperger syndrome
- MeSH terms
- Autistic Disorder, Base Sequence, Carrier Proteins, DNA Mutational Analysis, Female, Genetic Testing, Humans, Male, Molecular Sequence Data, Mutation, Nerve Tissue Proteins, Pedigree, In Situ Hybridization, Fluorescence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.